Worth reading
72In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
1800000
¥Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Completion of payment of the issue price for the 39th Stock Acquisition Rights through a third-party allotment (with clauses for adjustment of the exercise price)
Who receives how much
60,000,000 common shares (600,000 Stock Acquisition Rights, each representing 100 shares)
EVO FUND (600,000 Stock Acquisition Rights)
The lower thin line represents the existing number of shares to which these shares will be added.
¥3 per Stock Acquisition Right
Total issue value
¥1,800,000
Amount of funds to be raised
¥1,966,330,000 (the total payment amount for the Stock Acquisition Rights; this amount may increase or decrease due to adjustments to the exercise price and other factors)
Terms of the stock acquisition rights
Exercise price
Initial exercise price of ¥33. Subject to adjustment. Adjusted to 100% of the lowest closing price during the price calculation period. Lower exercise price limit of ¥17. In the event of an exercise exceeding the applicable limit, adjusted so that it does not fall below the closing price on the date of the resolution approving the issuance.
Exercise period
2 June 2026 to 2 June 2027
Number of Stock Acquisition Rights
Total number issued: 600,000. Unexercised balance: Not disclosed
Payment date
1 June 2026
Most recent equity financing
39th Stock Acquisition Rights with clauses for adjustment of the exercise price through a third-party allotment, as resolved on 15 May 2026
| Item | Details |
|---|---|
| Type of issuance or disposal | Completion of payment of the issue price for the 39th Stock Acquisition Rights through a third-party allotment (with clauses for adjustment of the exercise price) |
| Number of shares to be issued or disposed of | 60,000,000 common shares (600,000 Stock Acquisition Rights, each representing 100 shares) |
| Issue price and disposal price | ¥3 per Stock Acquisition Right |
| Total issue value | ¥1,800,000 |
| Amount of funds to be raised | ¥1,966,330,000 (the total payment amount for the Stock Acquisition Rights; this amount may increase or decrease due to adjustments to the exercise price and other factors) |
| Payment date | 1 June 2026 |
| Intended allottee | EVO FUND (600,000 Stock Acquisition Rights) |
| Exercise price | Initial exercise price of ¥33. Subject to adjustment. Adjusted to 100% of the lowest closing price during the price calculation period. Lower exercise price limit of ¥17. In the event of an exercise exceeding the applicable limit, adjusted so that it does not fall below the closing price on the date of the resolution approving the issuance. |
| Exercise period | 2 June 2026 to 2 June 2027 |
| Number of Stock Acquisition Rights | Total number issued: 600,000. Unexercised balance: Not disclosed |
| Most recent equity financing | 39th Stock Acquisition Rights with clauses for adjustment of the exercise price through a third-party allotment, as resolved on 15 May 2026 |
Items this document does not state (17)
Estimated issuance expensesSpecific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Payment of the total issue price for the issuance of these Stock Acquisition Rights pursuant to the Board of Directors' resolution dated 15 May 2026 was completed on 1 June 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.